0001179110-19-007208.txt : 20190605
0001179110-19-007208.hdr.sgml : 20190605
20190605164919
ACCESSION NUMBER: 0001179110-19-007208
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190528
FILED AS OF DATE: 20190605
DATE AS OF CHANGE: 20190605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilhoit Scott L.
CENTRAL INDEX KEY: 0001778589
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37569
FILM NUMBER: 19880357
MAIL ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE
STREET 2: SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Strongbridge Biopharma plc
CENTRAL INDEX KEY: 0001634432
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981130690
STATE OF INCORPORATION: L2
BUSINESS ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE, SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
BUSINESS PHONE: (610) 254-9200
MAIL ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE, SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
FORMER COMPANY:
FORMER CONFORMED NAME: Cortendo AB
DATE OF NAME CHANGE: 20150219
4
1
edgar.xml
FORM 4 -
X0306
4
2019-05-28
0
0001634432
Strongbridge Biopharma plc
SBBP
0001778589
Wilhoit Scott L.
900 NORTHBROOK DRIVE
SUITE 200
TREVOSE
PA
19053
0
1
0
0
Chief Commercial Officer
Employee Stock Option (right to buy)
2.84
2019-05-28
4
A
0
50000
0
A
2029-05-28
Common Stock
50000
50000
D
This option becomes exercisable as to 12,500 shares on May 28, 2020, with the remaining 37,500 shares becoming exercisable in twelve equal quarterly installments thereafter, provided the Reporting Person is employed by the Issuer on each vesting date.
/s/ Stephen J. Long, as attorney-in-fact
2019-06-05